Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues:
Product royalties		$ 1,745,896	$ 34,225	$ 1,796,135
Research revenues	33,606	220,194	226,843	397,337
Contract revenues	4,800	250,476	6,800	250,476
Total Revenues:	38,406	2,216,566	267,868	2,443,948
Cost of product royalties	(425,930)	796,525	(128,510)	808,954
Expenses:
Research and development	4,720,208	1,521,531	11,410,882	2,970,996
General and administrative	1,930,875	2,196,886	3,695,364	4,401,647
Related party general and administrative, net:	18,750	21,500	37,500	(339,000)
Impairment of intangible license		243,648		243,648
Total Expenses:	6,669,833	3,983,565	15,143,746	7,277,291
Loss from operations	(6,205,497)	(2,563,524)	(14,747,368)	(5,642,297)
Interest income	48,411	4,280	86,194	7,571
Derivative gain	1,046,869	3,306,470	559,556	6,176,442
Other income (expense), net	11,866	28,635	(16,044)	42,923
Net (loss) income	(5,098,351)	775,861	(14,117,662)	584,639
Net (loss) income attributable to common stockholders	$ (5,098,351)	$ 775,861	$ (14,117,662)	$ 584,639
Basic earnings per share:	$ (0.18)	$ 0.03	$ (0.52)	$ 0.03
Diluted earnings per share:	$ (0.18)	$ 0.01	$ (0.52)	$ 0.00